
Article 1 

1. The health claims listed in Annex I to this Regulation may be made on foods on the  Great Britain  market in compliance with the conditions laid down in that Annex.
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 2 

1. The health claims listed in Annex II to this Regulation  may not be made on foods on the  Great Britain  market.
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...Done at Brussels, 6 May 2011.
For the Commission
The President
José Manuel BARROSO
ANNEX I
Application – Relevant provisions of Regulation (EC) No 1924/2006 Applicant – Address Nutrient, substance, food or food category Claim Conditions of use of the claim Conditions and/or restrictions of use of the food and/or additional statement or warning EFSA opinion reference
Article 14(1)(b) health claim referring to children’s development and health Mead Johnson & Company, 3 rue Joseph Monier-BP 325, 92506 Rueil-Malmaison Cedex, France Docosahexaenoic acid (DHA) Docosahexaenoic acid (DHA) intake contributes to the normal visual development of infants up to 12 months of age. Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 100 mg of DHA.When the claim is used on follow-on formula, the food shall contain at least 0,3 % of the total fatty acids as DHA.  Q-2008-211, Q-2008-688, Q-2008-689
Article 14(1)(b) health claim referring to children’s development and health Merck Selbstmedikation GmbH, Roesslerstrasse 96, 64293 Darmstadt, Germany Docosahexaenoic acid (DHA) Docosahexaenoic acid (DHA) maternal intake contributes to the normal development of the eye of the foetus and breastfed infants. Information shall be given to pregnant and lactating women that the beneficial effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for adults, i.e. 250 mg DHA and eicosapentaenoic acid (EPA).The claim can be used only for food which provides a daily intake of at least 200 mg DHA.  Q-2008-675
Article 14(1)(b) health claim referring to children’s development and health Merck Selbstmedikation GmbH, Roesslerstrasse 96, 64293 Darmstadt, Germany Docosahexaenoic acid (DHA) Docosahexaenoic acid (DHA) maternal intake contributes to the normal brain development of the foetus and breastfed infants. Information shall be given to pregnant and lactating women that the beneficial effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for adults, i.e. 250 mg DHA and EPA.The claim can be used only for food which provides a daily intake of at least 200 mg DHA.  Q-2008-773
ANNEX II
Application – Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference
Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic acid (DHA) and arachidonic acid (ARA) Docosahexaenoic acid (DHA) and arachidonic acid (ARA) contribute to the optimal brain development of infants and young children. Q-2008-212
Article 14(1)(b) health claim referring to children’s development and health Lipil® Lipil® contributes to optimal brain development of infants and young children. Q-2008-690
Article 14(1)(b) health claim referring to children’s development and health Enfamil® Premium Enfamil® Premium contributes to optimal brain development of infants and young children. Q-2008-691